NCT00439959View on ClinicalTrials.gov

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

PHASE1TerminatedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Hepatitis C, ChronicHepatitis C

Interventions

DRUG

GSK625433/placebo

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY